🔴留意🔴管理層在2024年Q4業績電話會議上對目前臨床藥物的市場滲透率和峰值銷售的樂觀預期涉嫌誤導投資者——謹慎評估 一、原文摘錄:關於40%市場滲透率和20億美元收入目標的陳述 摘自:2025年3月31日業績電話會議 發言人:CEO Brian Sullivan 原文: 「We estimate the served market potential for our drug would be about $5 billion. Obviously, we're not going to get all of that. But we think it's not unreasonable to certainly shoot for, let's say, 40% penetration if our data is favorable. And certainly, that might be a goal of ours. And that translates to a $2 billion potential revenue opportunity for us.」 ——B...
Celcuity股票討論
一、原文摘錄:關於40%市場滲透率和20億美元收入目標的陳述
摘自:2025年3月31日業績電話會議
發言人:CEO Brian Sullivan
原文:
「We estimate the served market potential for our drug would be about $5 billion. Obviously, we're not going to get all of that. But we think it's not unreasonable to certainly shoot for, let's say, 40% penetration if our data is favorable. And certainly, that might be a goal of ours. And that translates to a $2 billion potential revenue opportunity for us.」
——B...
早安moomooers!在開盤鐘敲響之前,這裡有您需要了解的事情:
- 美國股指期貨在週二早盤交易時波動不大,在周一標普500指數和納斯達克綜合指數創下歷史新高之後。
- 盤前股市表現最為活躍的股票:marin software、exela technologies、阿特斯太陽能、celcuity inc和更多
市場快訊
美國股指期貨在週二早盤交易時波動不大,在周一標普500指數和納斯達克綜合指數創紀錄新高後...
暫無評論